Notes

Supposition Point Scores Huge on MiMedx Wager, Going against the short sellers provides led to large gains for Eiad Asbahi? s fund.
MARIETTA, Ga., May 30, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), a market leader inside advanced wound treatment and an emerging therapeutic biologics business, announced recently that the particular Company's board regarding directors (the "Board") has adopted the comprehensive plan to be able to refresh the formula in the Board. The plan was created simply by the Board within cooperation with one of the Company's largest investors, Prescience Point Money Management LLC ("Prescience Point"), and employs the completion regarding the Audit Committee's independent investigation straight into alleged wrongdoing by the prior mature management team and the engagement involving BDO USA, LLP as the Company's new independent authorized public accounting company.

Underneath the plan, half a dozen new directors, like MiMedx's new BOSS, Timothy R. Wright, can be added in order to the Board. Because a result, School II and Course III of typically the Board would comprise entirely of recent administrators after the Industry’s 2019 annual gathering of shareholders. The particular refreshment plan involves the appointment associated with three of Supposition Point's nominees, including M. Kathleen Behrens Wilsey, Ph. Deb. as the innovative Chairwoman of the particular Board, in addition to K. Todd Newton, which is expected to be able to end up being the Chairman regarding the Audit Panel after the Industry’s 2019 annual conference of shareholders.

"The MiMedx Board along with the current senior management team have recently been working tirelessly to address the after effects from the steps of the prior senior management team and have the Company back on the right track, inch said Charles 3rd there’s r. Evans, Chairman involving the Board. "Now that we include made substantial advancement on these face, it is moment to begin the particular Board transition and refreshment process. We are pleased in order to been employed by collaboratively together with Prescience Point to identify through adding fresh directors who bring exceptional experience plus track records to be able to MiMedx. With the Audit Committee's investigation complete and a decide to refresh the Board inside place, the Organization is actually in some sort of position to focus on future and enhance its business, for the benefit of all stakeholders. "

"We welcome the great plan to refresh the Board, and we anticipate MiMedx's future under brand new leadership. We are pleased that our cohesiveness has resulted within a reconstituted Board, with the help of six new directors with essential industry experience, relationships and reputational funds, " said Eiad Asbahi, Founder plus Managing Partner involving Prescience Point. "We committed to MiMedx mainly because we believe the Firm has immense prospective as a chief in advanced twisted care and beneficial biologics. We think MiMedx is in the path to unlock substantial aktionär value and risk-free a thriving long term for your Company. inch

Within the refreshment approach, Prescience Point nominee M. Kathleen Behrens Wilsey, Ph. M. will be appointed or perhaps nominated for selection to the Board plus is supposed to always be named the new Chairwoman of the Panel. Dr. Behrens Wilsey is currently typically the Chairwoman of Sarepta Therapeutics, Inc. (SRPT), a multi-billion-dollar healthcare research and drug development company targeted on the finding and development associated with unique RNA-targeted therapeutics for that treatment regarding rare neuromuscular illnesses. Dr. Behrens Wilsey previously served about the boards regarding Amylin Pharmaceuticals, Incorporation. (formerly AMLN) in addition to Abgenix, Inc. (formerly ABGX).

In addition to Doctor Behrens Wilsey, the Table will also have, or nominate for election to typically the Board, Richard M. Barry, James T. Bierman, K. Jake Newton, Mr. Wright and another representative who will be hired with the Company in addition to Prescience Point. Complete biographies of the particular anticipated new administrators appear at the final of this hit release.

The business expects to file it is preliminary proxy supplies for its 2018 Annual Meeting nowadays. The Board encourages shareholders to hang on to receive you can actually proxy materials as well as the Company's BLUE proxy card before voting.

Sidley Austin LLP is acting since legal advisor to be able to MiMedx. Olshan Frome Wolosky LLP is acting as legal advisor to Prescience Point.

About Rich J. Barry
Mister. Barry has offered as a movie director of Elcelyx Therapeutics, Inc., a personal pharmaceutical company, since February 2013 plus has served as being a Managing Member involving GSM Fund, LLC, a fund recognized for your sole objective of buying Elcelyx Therapeutics, since March 2013. Earlier inside his career, having been a founding member of Eastbourne Capital Administration LLC, a major equity hedge fund investing in a variety involving industries, including health and fitness care, and offered as the Controlling General Partner and even Portfolio Manager from 1999 to their close in the year 2010. Prior to that, he was a new Portfolio Manager in addition to Managing Director regarding Robertson Stephens Investment Management, an investment company, from 95 until 1999. Just before that, Mr. Craig spent over tough luck years in numerous functions in institutional equity and investment supervision firms, including Lazard Freres, Legg Mason and Merrill Lynch. Mr. Barry has served like a representative of Sarepta Therapeutics, Inc. (SRPT), the genetic medicine firm, since June 2015, and he has been a Partner and Prediction Board member associated with the San Diego Padres since 2009. Mr. Barry earlier served being a representative of Cluster Wi-fi, LLC, a software firm, from 2011 right up until 2014, along with BlackLight Power, Inc. (n/k/a Brilliant Light Strength, Inc. ), a good energy research firm, from 2009 right up until 2010. Mr. Craig holds a N. A. from Philadelphia State University.

Concerning M. Kathleen Behrens Wilsey, Ph. Deb.
Dr. Behrens Wilsey served as the member in the board of directors associated with each of Sarepta Therapeutics, Inc. (SRPT), a multi-billion dollar medical research and drug development company focused on the breakthrough and development of unique RNA-targeted therapeutics for the remedying of rare neuromuscular diseases, since March yr (Chairwoman of typically the Board since April 2015) and IGM Biosciences, Inc., a privately held biotechnology company, considering that January 2019. Doctor Behrens Wilsey did as an impartial life sciences advisor and investor since December 2009. The girl served as typically the Co-Founder, President, Key Executive Officer plus as a director of the KEW Group Inc., a private oncology services firm, from January the summer season until June 2014. Earlier in the woman career, Dr. Behrens Wilsey served being a general partner intended for selected venture finances for RS Investments, a mutual pay for firm, from mil novecentos e noventa e seis until December year. While Dr. Behrens Wilsey worked from RS Investments, by 1996 to 2002, she served as being a managing director on the firm and, from 2003 to January 2009, she dished up as an expert for the firm. During that time, Medical professional. Behrens Wilsey in addition served as a member of the President's Authorities of Advisors upon Science and Technological innovation (PCAST), from 2001 to 2009 as chairwoman of PCAST's Subcommittee on Individualized Medicine, as well as the Leader, director and chairwoman of the Nationwide Investment capital Association, the organization that supporters for public policy that supports typically the American Entrepreneurial ecosystem, from 1993 right up until 2000. Prior to that, she served while a general companion and managing representative for Robertson Stephens & Co., an investment company, from 1983 through 1996. The lady served as some sort of director of Amylin Pharmaceuticals, Inc. (formerly AMLN), a biopharmaceutical company, from 2009 before the company's sale this year to Bristol-Myers Squibb Co. Prior to that, your woman served around the plank of directors Abgenix, Inc. (formerly ABGX), a biopharmaceutical company, from 2001 until the company has been sold to Amgen, Inc. in 06. From 1997 in order to 2005, Doctor Behrens was a movie director of the Board on Science, Technologies and Economic Policy for that National Exploration Council. Dr. Behrens Wilsey was furthermore a Co-Founder regarding the Coalition intended for 21st Century Treatments, a trade relationship for brand spanking new generation analysis companies. Dr. Behrens Wilsey holds the B. S. in Biology and the Ph. D. in Microbiology through the College of California, Davis.

About James M. Bierman
Mr. Bierman served as President and Chief Executive Officer associated with Owens & Minor, Inc., a lot five hundred company along with a top distributor of healthcare and surgical items, from September 2014 to June 2015. Previously, eiad asbahi prescience point dished up in various various other senior roles with Owens & Small, including President and Chief Operating Official from August 2013 to September 2014, Executive Vice Us president and Chief Running Officer from Drive 2012 to Aug 2013, Executive Perversité President and Chief Financial Officer coming from April 2011 to March 2012, in addition to Senior Vice Chief executive and Chief Financial Officer from August 2007 to 04 2011. From 2001 to 2004, Mr. Bierman served seeing that Executive Vice Us president and Chief Economical Officer at Quintiles Transnational Corp. Before to joining Quintiles Transnational, Mr. Bierman was a spouse at Arthur Andersen LLP. Mr. Bierman currently serves on the board of directors of Tenet Healthcare Corporation (THC) and previously served on the boards of directors regarding Owens & Minor, Inc. (OMI) and Team Health Loge, Inc. (formerly TMH). Mr. Bierman earned his B. The. from Dickinson School and his M. B. A. from Cornell University's Nicholson Graduate School associated with Management.

About T. Todd Newton
Mister. eiad asbahi has, since 2014, served since Chief Executive Officer and some sort of member of the board of directors of Apollo Endosurgery, Inc. (APEN), a leader in the field of gastrointestinal healing endoscopy. From this year to 2014, Mr. Newton served like Executive Vice Leader and Chief Financial Officer at ArthroCare Corporation (ARTC), a new medical device organization, including from 2013 as Chief Functioning Officer. Prior to be able to his leadership with ArthroCare, Mr. Newton served in numerous professional officer roles, like President and Key Executive Officer, from Synenco Energy, Inc., a Canadian olive oil sands company. Coming from 1994 to 2004, Mr. Newton seemed to be a Partner from Deloitte & Patte LLP. Mr. Newton holds a B. B. A. throughout accounting through the College or university of Texas with San Antonio.

Regarding Timothy R. Wright
Mr. Wright started to be MiMedx's Ceo, effective as of May possibly 13, 2019. Formerly, Mr. Wright offered as a Partner at Signal Mountain Advisors, LLC, a consulting practice, considering that February 2011. Mr. Wright served like President and Chief Executive Officer regarding M2Gen Corp., the privately held cancer and health informatics company, between September 2017 and The month of september 2018. Prior to be able to M2Gen Corp., Mister. Wright served seeing that Executive Vice President, Mergers and Acquisitions, Method and Innovation intended for Teva Pharmaceutical Companies Ltd. ("Teva"), some sort of pharmaceutical company specialized in in generic medications, from April 2015 until August 2017. Before Teva, Mister. Wright was the founding partner regarding The Ohio Point out University Comprehensive Cancer Drug Development Institute. Mr. Wright furthermore served as Leader, Interim Chief Executive Officer and even a director involving Curaxis Pharmaceutical Firm ("Curaxis"), a pharmaceutic company specializing within the introduction of drugs for the treatment of Alzheimer's disease and various cancers, from This summer 2011 to July 2012. Curaxis experienced been experiencing monetary difficulties prior to Mr. eiad asbahi and, as a result, the business filed for Chapter 11 bankruptcy throughout July 2012. Mr. Wright has been a director involving Agenus, Inc. (Nasdaq: AGEN), an immune system oncology company, given that 2006 and the lead director since 2009. Mr. Wright also serves seeing that Chairperson of The Ohio State University Comprehensive Cancer Center Medicine Development Institute, assists as director of The Ohio State Creativity Foundation and sits on The Kansas State University College of Pharmacy Dean's Corporate Council. Mister. Wright earned a new Bachelor's of Science in Marketing coming from The Ohio Point out University.

About MiMedx
MiMedx� is a market leader in advanced wound care plus an emerging beneficial biologics company building and distributing individual placental tissue allografts with patent-protected processes for multiple industries of healthcare. The particular Company processes your placental tissue utilizing its proprietary PURION� process methodology, amongst other processes, to produce allografts by employing aseptic processing techniques in addition to airport terminal sterilization. MiMedx has supplied over one. 5 million allografts to date. For extra information, please go to www.mimedx.com.

About Supposition Point Capital Administration
Prescience Point Capital Management is a private investment administrator that employs forensic investigative processes to discover significant mispricings on global markets. It specializes in extensive investigations of difficult-to-analyze public companies in order to uncover significant components of the business that will have been overlooked or ignored simply by others.

Prescience Level manages private funds on behalf associated with its clients and principals and needs positions both extended and short inside support of the research. Prescience Point invests across a broad set involving equities that it believes have unusually large disparities involving what their root web based intrinsically worth and what their stock options cost. The firm started by entrepreneur Eiad Asbahi in 2009 which is based in Baton Rouge, LA. Prescience Level Capital Management will be a registered investment decision advisor with the State of Louisiana. Follow @PresciencePoint.

Free from harm Harbor Statement

This kind of press release includes forward-looking statements, including transactions in connection with plan involving MiMedx Group, Incorporation. (the "Company") to be able to refresh the Board, the effects of such refreshment within the Company plus expectations with regard to Board management. Forward-looking statements may be identified by words such as "believe, " "expect, inches "may, " "plan, " "potential, very well "will, " "would" and similar expressions and are based in current beliefs in addition to expectations. Forward-looking statements are be subject to dangers and uncertainties, in addition to the Company engagement investors against placing undue reliance on such statements.

Actual results may fluctuate materially from individuals set forth in the particular forward-looking statements as a result involving various factors, including the results involving any election associated with Class II or Class III company directors. There is no more assurance that the particular Board's nominees will be elected in the Company's 2018 total annual meeting of shareholders (the "2018 Gross annual Meeting") or typically the Company's 2019 annual meeting of shareholders. Any forward-looking transactions speak only because of the particular date of this pr release, and except since required by law, the organization assumes no obligation to update any forward-looking affirmation, whether as the result of fresh information, future occasions or otherwise.

Important Info
The Company intends to file a definitive proxy declaration and associated GLOWING BLUE proxy card inside of connection with the particular solicitation of unblock proxies for the 2018 Annual Meeting with the Securities and Exchange Commission (the "SEC"). Details with regards to the nominees in the Company's board regarding directors for selection at the 2018 Annual Meeting will certainly be within the proxy server statement. BEFORE MAKING ANY KIND OF VOTING DECISION, INVESTORS OF THE COMPANY ARE URGED TO READ ALL RELEVANT PAPERS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY'S DEFINITIVE WEB PROXY STATEMENT AND ANY KIND OF SUPPLEMENTS THERETO, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and shareholders can be able in order to have a copy associated with the definitive serwery proxy statement along with other papers filed by the Business free of charge in the SEC's web site at www.sec.gov. Typically the Company's shareholders will certainly also be ready to obtain, without charge, a copy in the definitive proxy server statement and additional relevant filed papers from the "SEC Filings" section involving you can actually website from www.mimedx.com.

Participants in the Application
Typically the Company, its administrators, its director candidates and certain of its executive officers will be participants in typically the solicitation of proxies from shareholders in respect of the 2018 Annual Getting together with. Information regarding the particular names of the particular Company's directors, director nominees and executive officers and the respective interests in the Organization by security coalition or otherwise is set forth in the particular Company's Current Statement on Form 8-K filed with the particular SEC on, may 35, 2019. Info relating to the interests of the participants in any proxy solicitation plus a description regarding their direct in addition to indirect interests, by security holdings or even otherwise, will furthermore be incorporated into virtually any proxy statement in addition to other relevant textiles to be submitted with the SEC, when and when they will available.
Read More: https://www.metooo.io/u/63e67bf4f96a3645ad827fee